Schedule IV controlled substances

In the United States, (+)-norpseudoephedrine, in its pure form, is considered a Schedule IV controlled substance. However, because of the small amounts of this alkaloid in ephedra plants or extracts, the Drug Enforcement Administration (DEA) had never stated or proposed that ephedra products were subject to the scheduling requirements of the Controlled Substances Act. Quite the contrary, DEA published a proposed rule in 1998 that stated DEA s intent to exempt legitimate ephedra products in finished form from regulation even as chemical mixtures. Other regulatory sanctions and actions on ephedra rendered action on this regulation moot. 

Pemoline (Cylert, others) is structurally dissimilar to methylphenidate but elicits similar changes in CNS function with minimal effects on the cardiovascular system. It is a schedule IV controlled substance in the United States and is employed in treating ADHD. It can be given once daily because of its long half-life. Clinical improvement may require treatment for 3 to 4 weeks. Use of pemoline has been associated with severe hepatic failure. 

Although these compounds show differences from the benzodiazepines in some pharmacological tests, with a reduced ability to cause physical dependence and minimal abuse potential, these drugs are listed as Schedule IV controlled substances. 

Which form is used to order Schedule IV controlled substances ... 

C-ll, C-lll, C-IV, controlled substance schedule 2, 3, and 4, respectively cap, capsule chew tab, chewable tablet CINV, chemotherapy-induced nausea and vomiting liquid, oral syrup, concentrate, or suspension OTC, nonprescription Rx, prescription supp, rectal suppository tab, tablet. 

There are established five schedules of controlled substances, to be known as schedules I, II, III, IV, and V. Such schedules shall initially consist of the substances listed in this section. The schedules established by this section shall be updated and republished on a semiannual basis during the two-year period beginning one year after October 27, 1970, and shall be updated and republished on an annual basis thereafter. 

The major and minor tranquilizers are legal as manufactured and prescribed and are classified as Schedule n,m, or IV controlled substances under the federal Controlled Substances Act (CSA). However, manufacturing, distributing, and selling these drugs without a prescription are subject to federal and state penalties. The CSA dictates penalties of up to 15 years imprisonment and fines up to 25,000 for unlawful distribution or possession of a controlled substance. 

Figure 2.3 This table explains the formal scheduling of drugs according to the Controlled Substances Act of 1970. Drugs are classified based upon their medical uses and potential for abuse. Although some states list Rohypnol in Schedule I, the federal government currently places the drug in Schedule IV.

Chloral hydrate is normally used today as a sleeping pill only if a person cannot take other sleeping pills called benzodiazepines. It is marketed under the brand name Noctec. The drug comes in liquid or capsule form and may be swallowed or inserted into the rectum. Chloral hydrate is listed on Schedule IV of the Controlled Substances Act, which means that it has a legitimate medical use even though it may be abused. 

Prescriptions for Schedule III, IV, or V controlled substances may be written, oral, or faxed. Refills may be authorized by the practitioner provided they are indicated on the face of the prescription. A Schedule III, IV, or V controlled substance prescription may be refilled up to a maximum of five times within a 6-month period of time after the date of issue. The key is the date of issue not the date of filling. The 6-month time period runs from the date the prescription was issued not the date that the pharmacy fills the prescription. After five refills have been exhausted or the 6-month timeframe has been expired, the patient must obtain a new prescription. 

A pharmacist must record the following information on the back of a prescription when a pharmacist refills a Schedule III, IV, or V controlled substance prescription ... 

Fax prescriptions for Schedules III, IV, or V controlled substances are permissible and the fax is treated as the original prescription. 

Telephone Authorization for Schedule III, IV, orV Controlled Substance Prescriptions... 

Provided state allows, Schedule III, IV, or V controlled substance refill prescriptions may be transferred between pharmacies on a onetime basis. For those pharmacies that electronically share a real time online database (i.e., chain pharmacies), the pharmacy may transfer up to the maximum number of refills allowed by the practitioner on the prescription. The requirements necessary for the transfer are as follows ... 

There are still some states that permit the sale of Schedule II, III, IV, and V controlled substances over the counter. Only those controlled substances that are not a prescription item under the Federal Food, Drug and Cosmetic Act maybe dispensed without a prescription at retail provided that ... 

A pharmacist may receive a controlled substance prescription for Schedule III, IV, or V as a written prescription a facsimile transmitted by the practitioner or an oral prescription. If the prescription is an oral prescription the pharmacist must immediately reduce the prescription to writing ensming that the prescription contains all the necessary information required by the DEA and state law. At the printing of this book, the electronic transmission of controlled substance prescriptions is not considered valid. However, a prescription received via tbe Internet could be treated as an oral prescription. The pharmacist would be required to contact tbe practitioner and obtain tbe information from the practitioner including all the required information. The practitioner has 7 days to deliver a written follow-up prescription to the pharmacy. For oral Schedule III, IV, and V controlled substance prescriptions, the pharmacy is not responsible for notifying the DEA if a written follow-up prescription within the 7-day requirement is not received. The pharmacy does have an obligation to make a notation on the back of the oral prescription that it did not receive the written follow up within the 7-day period of time. 

Schedule III, IV, and V controlled substance prescriptions may be transmitted to the pharmacy by which of the following means ... 

---